Collagen Peptide Supplementation: Systematic Reviews and Meta-Analyses on Skin, Joint, and Bone Outcomes

Background

Collagen peptides — also referred to as hydrolyzed collagen or collagen hydrolysate — are bioactive fragments produced by enzymatic degradation of native collagen proteins. As the most abundant structural protein in the human body, collagen is critical to the integrity of skin, cartilage, bone, and connective tissue. Oral collagen peptide supplementation has become one of the fastest-growing segments of the nutritional supplement market, driven by consumer interest in skin anti-aging, joint health, and bone density preservation. Over the past decade, a substantial number of randomized controlled trials (RCTs) have been conducted, enabling systematic reviews and meta-analyses to assess the evidence base with greater statistical rigor.

Methods

Several systematic reviews and meta-analyses have synthesized the available RCT evidence. A 2023 systematic review and meta-analysis by de Miranda and colleagues assessed 26 RCTs involving 1,721 participants to evaluate the effects of hydrolyzed collagen on skin hydration and elasticity. A separate systematic review by Kirmse and colleagues examined the effects of collagen peptide supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise across 15 studies. A 2025 meta-analysis evaluated the efficacy of collagen peptide supplementation specifically on bone mineral density and muscle health outcomes. An additional 2024 meta-analysis assessed collagen combined with physical training on strength, musculotendinous remodeling, and body composition in healthy adults.

Key Findings

Skin Outcomes

The meta-analysis of 26 RCTs found that hydrolyzed collagen supplementation significantly improved both skin hydration and skin elasticity compared to placebo. Individual RCTs reported that low-molecular-weight collagen peptides (1,000–5,000 daltons) improved stratum corneum hydration, dermal elasticity, and visible wrinkling within 6 to 12 weeks. One double-blind, placebo-controlled study demonstrated significant hydration increases from a baseline of 43.7 to 51.7 arbitrary units at 8 weeks in the collagen group, with concurrent improvements in skin elasticity.

Joint Outcomes

Systematic review evidence indicates that collagen peptide supplementation is most beneficial in improving joint functionality and reducing joint pain, particularly in populations with osteoarthritis or exercise-related joint stress. When combined with exercise, collagen supplementation may support management of degenerative joint disorders through stimulatory effects on the extracellular matrix of cartilage and connective tissues.

Bone Outcomes

Meta-analytic data demonstrated that collagen peptide supplementation significantly increased bone mineral density at the femoral neck and lumbar spine. These effects appeared most pronounced in postmenopausal women and older adults at risk for osteoporosis.

Musculoskeletal and Body Composition

The analysis of collagen combined with physical training found significant improvements in fat-free mass, tendon morphology, muscle mass, maximal strength, and recovery following exercise-induced muscle damage.

Implications

The convergence of multiple systematic reviews and meta-analyses provides moderate-quality evidence that collagen peptide supplementation produces measurable benefits for skin hydration and elasticity, joint pain and function, and bone mineral density. The low-risk side effect profile of oral collagen peptides and their relatively low cost make them an accessible intervention for age-related tissue changes. The evidence is strongest for skin outcomes, where the largest number of well-designed RCTs has been conducted.

Limitations

Despite positive pooled effects, the evidence base has notable limitations. Many included RCTs had small sample sizes (fewer than 100 participants), short durations (8 to 24 weeks), and heterogeneous formulations that varied in collagen source (bovine, porcine, marine), molecular weight, and daily dose (2.5 to 15 grams). Publication bias may inflate effect sizes, and several trials were industry-funded. The bone mineral density findings, while statistically significant, require confirmation in larger, longer-duration trials before firm clinical recommendations can be made.